APGE Financing Cash Flow

Apogee Therapeutics Inc · Financing Cash Flow

APGE logo

APGE Financing Cash Flow

Latest reported$912.87M
APGE TTM Cash from Financing ($168.32M → $912.87M)
High-resolution chart · PNG

APGE financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Apogee Therapeutics Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
912,872,000
807,035,000
396,490,000
65,896,000
46,541,000
45,211,000
495,109,000
450,540,000
767,455,000
765,911,000
315,391,000
474,100,000
161,649,000
163,317,000
168,317,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.